Roche at-home COVID test granted FDA Emergency Use Authorization
Seeking Alpha2021-12-26
- The FDA has grantedEmergency Use Authorization to Roche's(OTCQX:RHHBY) COVID-19 at-home test.
- The test uses a nasal swab and provides results in as little as 20 minutes.
- The test will become available next month. Roche says that it will be able to produce "tens of millions" of tests per month.
- In a study, the Roche test had a relative sensitivity of 95.3% and a relative specificity of 100%.
- Earlier this week, President Biden said the federal government would start distributing 500M at-home tests in January.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.